vs
PREFORMED LINE PRODUCTS CO（PLPC）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
PREFORMED LINE PRODUCTS CO的季度营收约是Tarsus Pharmaceuticals, Inc.的1.1倍（$173.1M vs $151.7M），PREFORMED LINE PRODUCTS CO净利率更高（4.9% vs -5.5%，领先10.4%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 3.6%），Tarsus Pharmaceuticals, Inc.自由现金流更多（$13.0M vs $11.8M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 10.8%）
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
PLPC vs TARS — 直观对比
营收规模更大
PLPC
是对方的1.1倍
$151.7M
营收增速更快
TARS
高出124.8%
3.6%
净利率更高
PLPC
高出10.4%
-5.5%
自由现金流更多
TARS
多$1.2M
$11.8M
两年增速更快
TARS
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $173.1M | $151.7M |
| 净利润 | $8.4M | $-8.4M |
| 毛利率 | 29.8% | — |
| 营业利润率 | 6.8% | -5.3% |
| 净利率 | 4.9% | -5.5% |
| 营收同比 | 3.6% | 128.4% |
| 净利润同比 | -19.3% | 63.8% |
| 每股收益（稀释后） | $1.72 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLPCTARS
| Q4 25 | $173.1M | $151.7M | ||
| Q3 25 | $178.1M | $118.7M | ||
| Q2 25 | $169.6M | $102.7M | ||
| Q1 25 | $148.5M | $78.3M | ||
| Q4 24 | $167.1M | $66.4M | ||
| Q3 24 | $147.0M | $48.1M | ||
| Q2 24 | $138.7M | $40.8M | ||
| Q1 24 | $140.9M | $27.6M |
净利润PLPCTARS
| Q4 25 | $8.4M | $-8.4M | ||
| Q3 25 | $2.6M | $-12.6M | ||
| Q2 25 | $12.7M | $-20.3M | ||
| Q1 25 | $11.5M | $-25.1M | ||
| Q4 24 | $10.5M | $-23.1M | ||
| Q3 24 | $7.7M | $-23.4M | ||
| Q2 24 | $9.4M | $-33.3M | ||
| Q1 24 | $9.6M | $-35.7M |
毛利率PLPCTARS
| Q4 25 | 29.8% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 32.7% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 31.1% | — | ||
| Q2 24 | 31.9% | — | ||
| Q1 24 | 31.3% | — |
营业利润率PLPCTARS
| Q4 25 | 6.8% | -5.3% | ||
| Q3 25 | 7.4% | -12.2% | ||
| Q2 25 | 10.1% | -21.6% | ||
| Q1 25 | 8.8% | -33.5% | ||
| Q4 24 | 10.5% | -36.8% | ||
| Q3 24 | 7.1% | -52.3% | ||
| Q2 24 | 8.1% | -81.6% | ||
| Q1 24 | 8.2% | -136.5% |
净利率PLPCTARS
| Q4 25 | 4.9% | -5.5% | ||
| Q3 25 | 1.5% | -10.6% | ||
| Q2 25 | 7.5% | -19.8% | ||
| Q1 25 | 7.8% | -32.1% | ||
| Q4 24 | 6.3% | -34.8% | ||
| Q3 24 | 5.2% | -48.7% | ||
| Q2 24 | 6.8% | -81.6% | ||
| Q1 24 | 6.8% | -129.4% |
每股收益（稀释后）PLPCTARS
| Q4 25 | $1.72 | $-0.17 | ||
| Q3 25 | $0.53 | $-0.30 | ||
| Q2 25 | $2.56 | $-0.48 | ||
| Q1 25 | $2.33 | $-0.64 | ||
| Q4 24 | $2.13 | $-0.57 | ||
| Q3 24 | $1.54 | $-0.61 | ||
| Q2 24 | $1.89 | $-0.88 | ||
| Q1 24 | $1.94 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $417.3M |
| 总债务越低越好 | $38.3M | $72.4M |
| 股东权益账面价值 | $475.5M | $343.4M |
| 总资产 | $653.6M | $562.2M |
| 负债/权益比越低杠杆越低 | 0.08× | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资PLPCTARS
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | — | $381.1M | ||
| Q1 25 | — | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | — | $323.6M | ||
| Q1 24 | — | $298.5M |
总债务PLPCTARS
| Q4 25 | $38.3M | $72.4M | ||
| Q3 25 | $36.0M | $72.3M | ||
| Q2 25 | $31.8M | $72.1M | ||
| Q1 25 | $29.1M | $72.0M | ||
| Q4 24 | $20.8M | $71.8M | ||
| Q3 24 | $27.2M | $71.7M | ||
| Q2 24 | $31.6M | $71.6M | ||
| Q1 24 | $55.0M | $29.9M |
股东权益PLPCTARS
| Q4 25 | $475.5M | $343.4M | ||
| Q3 25 | $466.3M | $335.1M | ||
| Q2 25 | $460.7M | $332.6M | ||
| Q1 25 | $435.8M | $342.5M | ||
| Q4 24 | $422.3M | $224.5M | ||
| Q3 24 | $429.0M | $237.5M | ||
| Q2 24 | $416.2M | $252.2M | ||
| Q1 24 | $413.4M | $275.2M |
总资产PLPCTARS
| Q4 25 | $653.6M | $562.2M | ||
| Q3 25 | $644.6M | $534.6M | ||
| Q2 25 | $631.5M | $495.0M | ||
| Q1 25 | $592.5M | $500.8M | ||
| Q4 24 | $573.9M | $377.0M | ||
| Q3 24 | $592.0M | $376.3M | ||
| Q2 24 | $572.6M | $376.8M | ||
| Q1 24 | $586.1M | $349.3M |
负债/权益比PLPCTARS
| Q4 25 | 0.08× | 0.21× | ||
| Q3 25 | 0.08× | 0.22× | ||
| Q2 25 | 0.07× | 0.22× | ||
| Q1 25 | 0.07× | 0.21× | ||
| Q4 24 | 0.05× | 0.32× | ||
| Q3 24 | 0.06× | 0.30× | ||
| Q2 24 | 0.08× | 0.28× | ||
| Q1 24 | 0.13× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.9M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $11.8M | $13.0M |
| 自由现金流率自由现金流/营收 | 6.8% | 8.6% |
| 资本支出强度资本支出/营收 | 5.9% | 4.2% |
| 现金转化率经营现金流/净利润 | 2.60× | — |
| 过去12个月自由现金流最近4个季度 | $33.3M | $-22.3M |
8季度趋势，按日历期对齐
经营现金流PLPCTARS
| Q4 25 | $21.9M | $19.3M | ||
| Q3 25 | $18.9M | $18.3M | ||
| Q2 25 | $26.9M | $-29.4M | ||
| Q1 25 | $5.7M | $-20.7M | ||
| Q4 24 | $24.1M | $-22.2M | ||
| Q3 24 | $9.4M | $-8.7M | ||
| Q2 24 | $28.3M | $-14.4M | ||
| Q1 24 | $5.8M | $-37.8M |
自由现金流PLPCTARS
| Q4 25 | $11.8M | $13.0M | ||
| Q3 25 | $8.3M | $16.3M | ||
| Q2 25 | $18.6M | $-30.4M | ||
| Q1 25 | $-5.3M | $-21.2M | ||
| Q4 24 | $20.6M | $-22.3M | ||
| Q3 24 | $5.8M | $-8.9M | ||
| Q2 24 | $24.6M | $-15.4M | ||
| Q1 24 | $1.8M | $-38.0M |
自由现金流率PLPCTARS
| Q4 25 | 6.8% | 8.6% | ||
| Q3 25 | 4.7% | 13.8% | ||
| Q2 25 | 10.9% | -29.6% | ||
| Q1 25 | -3.6% | -27.1% | ||
| Q4 24 | 12.3% | -33.5% | ||
| Q3 24 | 3.9% | -18.6% | ||
| Q2 24 | 17.7% | -37.8% | ||
| Q1 24 | 1.3% | -137.5% |
资本支出强度PLPCTARS
| Q4 25 | 5.9% | 4.2% | ||
| Q3 25 | 6.0% | 1.6% | ||
| Q2 25 | 4.9% | 1.0% | ||
| Q1 25 | 7.4% | 0.8% | ||
| Q4 24 | 2.1% | 0.1% | ||
| Q3 24 | 2.4% | 0.6% | ||
| Q2 24 | 2.7% | 2.5% | ||
| Q1 24 | 2.8% | 0.6% |
现金转化率PLPCTARS
| Q4 25 | 2.60× | — | ||
| Q3 25 | 7.21× | — | ||
| Q2 25 | 2.12× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 2.30× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 3.02× | — | ||
| Q1 24 | 0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
